Skip to main content
ADBIOTECH Co.,Ltd. logo

ADBIOTECH Co.,Ltd. — Investor Relations & Filings

Ticker · 179530 ISIN · KR7179530001 KO Manufacturing
Filings indexed 415 across all filing types
Latest filing 2025-07-03 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 179530

About ADBIOTECH Co.,Ltd.

http://www.adbiotech.com

ADBIOTECH Co., Ltd. is a biotechnology company specializing in the development and commercialization of immune antibodies. The company's core competency is IgY (Immunoglobulin in Yolk) technology, which utilizes antibodies derived from eggs to create alternatives to conventional vaccines and antibiotics. Its product portfolio targets the livestock, aquaculture, and human health sectors, with applications for disease prevention and treatment in animals like salmon and shrimp, as well as human-focused developments for conditions related to Helicobacter pylori and cholesterol. The company manages the entire value chain from research and development to production and sales. ADBIOTECH is also expanding its technological capabilities into VHH (nanobody) technology, with a strategic focus on the global companion animal market.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement from Addbiotech. It details the finalization of a private placement of convertible bonds (CB), including the issuance amount, payment date, and reference to the initial board resolution. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2025-07-03 Korean
유상증자결정(종속회사의주요경영사항)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory announcement regarding a 'Capital Increase' (유상증자결정) for a subsidiary company (마켓트리). It details the number of new shares, the purpose of the funds, the issuance method (shareholder allocation), and the board resolution date. This falls under the category of capital and financing updates.
2025-06-24 Korean
전환청구권행사 (제6회차)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (AdBiotech) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds (CB). This involves the issuance of new shares resulting from the conversion of debt into equity. According to the provided categories, 'SHA' (Share Issue/Capital Change) is the most appropriate classification for announcements regarding new share issues or capital changes resulting from such corporate actions.
2025-06-24 Korean
타법인주식및출자증권취득결정
Capital/Financing Update Classification · 98% confidence The document is a regulatory filing from a Korean company (AdBiotech) announcing the acquisition of shares in another company (MarketTree). This type of disclosure, which details the acquisition of equity in another entity, is a standard corporate regulatory announcement. Since it does not fit into specific categories like M&A (which usually implies larger scale mergers/takeovers) or share issues, it falls under the general regulatory filing category.
2025-06-24 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details changes in share ownership (specifically the sale of convertible bonds) by a major shareholder (Golden Core No. 1). This falls under the category of Major Shareholding Notification.
2025-06-23 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details changes in share ownership (specifically the sale of convertible bonds) by a major shareholder (Golden Core No. 2) in the company 'Adbiotech'. This falls under the category of Major Shareholding Notification.
2025-06-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.